W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

The European Union is exploring a broader set of possible counter-measures against the United States as prospects for an ...

Targeting European allies won't fix any of our problems with China, or improve health care, writes Josh Steuterman.

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

South Koreans’ perceptions of the US have taken a dive amid Trump’s ‘America First’ foreign policy and trade agenda.

Tariffs pose rising inflation and rate cut risks for H2 2025 as CPI data hints at early price pressures in key goods. See why ...

Trump’s 30% tariff threat could rupture the US-EU trade relationship. The EU prepares €72B in countermeasures as markets ...

Already late with carrying out his administration's prior threats around pharmaceutical tariffs, President Donald Trump has ...

Johnson and Johnson beat Wall Street’s quarterly sales expectations and raised its full-year outlook, a show of confidence as ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

CANBERRA, July 9 (Xinhua) -- The Australian government is very concerned about U.S. threats to impose increased tariffs on pharmaceutical and copper imports, Treasurer Jim Chalmers said on Wednesday.